March 29 (Reuters) - Biotech company Aveo Pharmaceuticals Inc will pay $4 million to settle civil charges that it misled investors about U.S. regulators' concerns about its drug to treat kidney cancer, the Securities and Exchange Commission said on Tuesday.
Read more
No comments:
Post a Comment